Aaron S Wallace1, Fred Willis2, Eric Nwaze3, Boubacar Dieng2, Naawa Sipilanyambe2, Danni Daniels4, Emmanuel Abanida3, Alex Gasasira5, Mustapha Mahmud3, Tove K Ryman6. 1. Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: AWallace@cdc.gov. 2. Maternal and Child Health Team, UNICEF, Abuja, Nigeria. 3. Immunization Division, National Primary Health, Abuja, Nigeria. 4. Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. 5. Vaccines, Immunizations and Biologicals, World Health Organization, Abuja, Nigeria. 6. Bill and Melinda Gates Foundation, Global Immunization Division, Centers for Disease Control and Prevention, Seattle, WA, USA.
Abstract
INTRODUCTION: The introduction of new vaccines highlights concerns about high vaccine wastage, knowledge of wastage policies and quality of stock management. However, an emphasis on minimizing wastage rates may cause confusion when recommendations are also being made to reduce missed opportunities to routinely vaccinate children. This concern is most relevant for lyophilized vaccines without preservatives [e.g. measles-containing vaccine (MCV)], which can be used for a limited time once reconstituted. METHODS: We sampled 54 health facilities within 11 local government areas (LGAs) in Nigeria and surveyed health sector personnel regarding routine vaccine usage and wastage-related knowledge and practices, conducted facility exit interviews with caregivers of children about missed opportunities for routine vaccination, and abstracted vaccine stock records and vaccination session data over a 6-month period to calculate wastage rates and vaccine vial usage patterns. RESULTS: Nearly half of facilities had incomplete vaccine stock data for calculating wastage rates. Among facilities with sufficient data, mean monthly facility-level wastage rates were between 18 and 35% across all reviewed vaccines, with little difference between lyophilized and liquid vaccines. Most (98%) vaccinators believed high wastage led to recent vaccine stockouts, yet only 55% were familiar with the multi-dose vial policy for minimizing wastage. On average, vaccinators reported that a minimum of six children must be present prior to opening a 10-dose MCV vial. Third dose of diphtheria-tetanus-pertussis vaccine (DTP3) was administered in 84% of sessions and MCV in 63%; however, the number of MCV and DTP3 doses administered were similar indicating the number of children vaccinated with DTP3 and MCV were similar despite less frequent MCV vaccination opportunities. Among caregivers, 30% reported being turned away for vaccination at least once; 53% of these children had not yet received the missed dose. DISCUSSION: Our findings show inadequate implementation of vaccine management guidelines, missed opportunities to vaccinate, and lyophilized vaccine wastage rates below expected rates. Missed opportunities for vaccination may occur due to how the health system's contradicting policies may force health workers to prioritize reduced wastage rates over vaccine administration, particularly for multi-dose vials. Published by Elsevier Ltd.
INTRODUCTION: The introduction of new vaccines highlights concerns about high vaccine wastage, knowledge of wastage policies and quality of stock management. However, an emphasis on minimizing wastage rates may cause confusion when recommendations are also being made to reduce missed opportunities to routinely vaccinate children. This concern is most relevant for lyophilized vaccines without preservatives [e.g. measles-containing vaccine (MCV)], which can be used for a limited time once reconstituted. METHODS: We sampled 54 health facilities within 11 local government areas (LGAs) in Nigeria and surveyed health sector personnel regarding routine vaccine usage and wastage-related knowledge and practices, conducted facility exit interviews with caregivers of children about missed opportunities for routine vaccination, and abstracted vaccine stock records and vaccination session data over a 6-month period to calculate wastage rates and vaccine vial usage patterns. RESULTS: Nearly half of facilities had incomplete vaccine stock data for calculating wastage rates. Among facilities with sufficient data, mean monthly facility-level wastage rates were between 18 and 35% across all reviewed vaccines, with little difference between lyophilized and liquid vaccines. Most (98%) vaccinators believed high wastage led to recent vaccine stockouts, yet only 55% were familiar with the multi-dose vial policy for minimizing wastage. On average, vaccinators reported that a minimum of six children must be present prior to opening a 10-dose MCV vial. Third dose of diphtheria-tetanus-pertussis vaccine (DTP3) was administered in 84% of sessions and MCV in 63%; however, the number of MCV and DTP3 doses administered were similar indicating the number of children vaccinated with DTP3 and MCV were similar despite less frequent MCV vaccination opportunities. Among caregivers, 30% reported being turned away for vaccination at least once; 53% of these children had not yet received the missed dose. DISCUSSION: Our findings show inadequate implementation of vaccine management guidelines, missed opportunities to vaccinate, and lyophilized vaccine wastage rates below expected rates. Missed opportunities for vaccination may occur due to how the health system's contradicting policies may force health workers to prioritize reduced wastage rates over vaccine administration, particularly for multi-dose vials. Published by Elsevier Ltd.
Authors: Bruce Y Lee; Tina-Marie Assi; Korngamon Rookkapan; Diana L Connor; Jayant Rajgopal; Vorasith Sornsrivichai; Shawn T Brown; Joel S Welling; Bryan A Norman; Sheng-I Chen; Rachel R Bailey; Ann E Wiringa; Angela R Wateska; Anirban Jana; Willem G Van Panhuis; Donald S Burke Journal: Vaccine Date: 2011-03-23 Impact factor: 3.641
Authors: Tina-Marie Assi; Shawn T Brown; Ali Djibo; Bryan A Norman; Jayant Rajgopal; Joel S Welling; Sheng-I Chen; Rachel R Bailey; Souleymane Kone; Hailu Kenea; Diana L Connor; Angela R Wateska; Anirban Jana; Stephen R Wisniewski; Willem G Van Panhuis; Donald S Burke; Bruce Y Lee Journal: BMC Public Health Date: 2011-06-02 Impact factor: 3.295
Authors: Martha Velandia-González; Silas Pierson Trumbo; José Luis Díaz-Ortega; Pamela Bravo-Alcántara; M Carolina Danovaro-Holliday; Vance Dietz; Cuauhtémoc Ruiz-Matus Journal: BMC Int Health Hum Rights Date: 2015-02-21
Authors: Leora R Feldstein; Roberta Sutton; Mohamed F Jalloh; Lauren Parmley; Maria Lahuerta; Adewale Akinjeji; Anthony Mansaray; Oliver Eleeza; Tom Sesay; Shibani Kulkarni; Laura Conklin; Aaron S Wallace Journal: J Glob Health Date: 2020-06 Impact factor: 4.413
Authors: Patrick T Wedlock; Elizabeth A Mitgang; Assaf P Oron; Brittany L Hagedorn; Jim Leonard; Shawn T Brown; Jennifer Bakal; Sheryl S Siegmund; Bruce Y Lee Journal: Vaccine Date: 2019-03-23 Impact factor: 3.641
Authors: Sanne M Thysen; Aksel Karl Georg Jensen; Amabelia Rodrigues; Igualdino da Silva Borges; Peter Aaby; Christine Benn; Ane Fisker Journal: BMJ Open Date: 2019-09-24 Impact factor: 2.692
Authors: Aaron S Wallace; Kong Krey; John Hustedt; Eleanor Burnett; Narin Choun; Danni Daniels; Margaret L Watkins; Sann Chan Soeung; Richard Duncan Journal: Vaccine Date: 2018-06-19 Impact factor: 3.641